Liposomal formulations are used in cancer treatment to address several challenges associated with traditional chemotherapy. Conventional chemotherapy often leads to systemic toxicity, affecting normal cells and causing severe side effects. Liposomes can preferentially accumulate in tumor tissues through the enhanced permeability and retention (EPR) effect, reducing off-target toxicity and enhancing the therapeutic efficacy of anticancer drugs.
